what drug company makes eliquis

Eliquis is manufactured by Bristol Myers Squibb (BMS) in partnership with Pfizer.
This blockbuster blood thinner, used to prevent strokes and blood clots, stems from a long-standing alliance between the two pharma giants.

Key Manufacturers

Bristol Myers Squibb leads development and marketing, often listed as the primary manufacturer in official documents and prescribing info.

Pfizer co-markets Eliquis globally through their BMS-Pfizer Alliance, sharing revenues and recent initiatives like direct-to-patient sales.

The drug's active ingredient, apixaban, is produced under this joint venture, making both companies responsible for its distribution.

Recent Developments

In July 2025, BMS and Pfizer launched Eliquis360 Support, offering the drug at a 40% discount (from $606 to $346 monthly) directly to uninsured patients, bypassing middlemen amid Trump administration pressures on drug pricing.

Pfizer noted in 2024 a government-set "maximum fair price" of $231 for Medicare starting January 2026 under the Inflation Reduction Act.

Generics were FDA-approved but face patent challenges, potentially delaying launches until 2026.

Quick Facts

• Drug Class : Factor Xa inhibitor anticoagulant.

• Top Uses : Stroke prevention in atrial fibrillation; DVT/PE treatment.

• U.S. Sales : Blockbuster status with millions of prescriptions, over 90% insured.

• Official Sites : eliquis.bmscustomerconnect.com (BMS-focused); Pfizer announcements confirm partnership.

TL;DR: Bristol Myers Squibb and Pfizer make Eliquis via their alliance—BMS handles core manufacturing, both drive sales and innovations.

Information gathered from public forums or data available on the internet and portrayed here.